ETC-159 - 98%, high purity , CAS No.1638250-96-0, Inhibitor of porcupine O-acyltransferase

Item Number
E413550
Grouped product items
SKUSizeAvailabilityPrice Qty
E413550-5mg
5mg
In stock
$53.90
E413550-10mg
10mg
In stock
$86.90
E413550-25mg
25mg
In stock
$162.90
E413550-50mg
50mg
In stock
$271.90
E413550-100mg
100mg
In stock
$489.90
E413550-250mg
250mg
In stock
$1,102.90

PORCN Inhibitors

Basic Description

SynonymsETC-159 | 1638250-96-0 | ETC-1922159 | 2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(6-phenylpyridazin-3-yl)acetamide | ETC159 | 2-(1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(6-phenylpyridazin-3-yl)acetamide | CHEMBL3633802 | 5L854240DQ | 7H-Purine-7-acetamide
Specifications & PurityMoligand™, ≥98%
Biochemical and Physiological MechanismsETC-159 (ETC-1922159) is an orally available, potent porcupine inhibitor with an IC50 of 2.9 nM for inhibiting β-catenin reporter activity in STF3A cells.
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionInhibitor of porcupine O-acyltransferase
Product Description

Information

ETC-159 ETC-159 (ETC-1922159) is an orally available, potent porcupine inhibitor with an IC50 of 2.9 nM for inhibiting β-catenin reporter activity in STF3A cells.


Targets

Porcn


In vitro

ETC-159 treatment causes decreased abundance of Wnt3a-stabilized β-catenin protein in both mouse L cells and HEK293 cells. ETC-159 inhibits β-catenin signaling in response to multiple active Wnts. ETC-159 inhibits mouse PORCN with an IC50 of 18.1\u2009nM, whereas the IC50 for Xenopus Porcn is approximately fourfold higher (70\u2009nM).


In vivo

ETC-159 is orally bioavailable and effectively inhibits the growth of mouse mammary tumor virus-Wnt1 tumors. After a single oral dose of 5\u2009mg/kg in mice, ETC-159 is rapidly absorbed into the blood with a Tmax of ~0.5\u2009h and oral bioavailability of 100%. The plasma half-life is ~1.18\u2009h and its concentration in the blood remained above the in vitro IC50 for at least 16\u2009h. Treatment of mice with increasing doses of ETC-159 leads to a dose-related increase in exposure. ETC-159 also effectively inhibits Wnt autocrine signaling and growth of teratocarcinomas. ETC-159 effectively inhibits the growth and induces differentiation of colon cancers with RSPO translocations and induces global remodeling of gene expression. Suppression of Wnt/β-catenin signaling with ETC-159 in genetically defined tumors induces irreversible cellular differentiation thus preventing regrowth of these tumors.


Cell Research(from reference)

Cell lines:Mouse L cells 

Concentrations:100\u2009nM 

Incubation Time:0-24 h 

Product Properties

ALogP1.404
HBD Count1
Rotatable Bond4

Associated Targets(Human)

PORCN Tchem Protein-serine O-palmitoleoyltransferase porcupine (2 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HEK293 (82097 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PORCN Tchem Probable protein-cysteine N-palmitoyltransferase porcupine (135 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Hdac6 Histone deacetylase 6 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Names and Identifiers

IUPAC Name 2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(6-phenylpyridazin-3-yl)acetamide
INCHI InChI=1S/C19H17N7O3/c1-24-17-16(18(28)25(2)19(24)29)26(11-20-17)10-15(27)21-14-9-8-13(22-23-14)12-6-4-3-5-7-12/h3-9,11H,10H2,1-2H3,(H,21,23,27)
InChi Key QTRXIFVSTWXRJJ-UHFFFAOYSA-N
Canonical SMILES CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(=O)NC3=NN=C(C=C3)C4=CC=CC=C4
Isomeric SMILES CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(=O)NC3=NN=C(C=C3)C4=CC=CC=C4
PubChem CID 86280523
Molecular Weight 391.38

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

12 results found

Lot NumberCertificate TypeDateItem
F23161265Certificate of AnalysisMay 25, 2023 E413550
F23161267Certificate of AnalysisMay 25, 2023 E413550
F23161268Certificate of AnalysisMay 25, 2023 E413550
F23161270Certificate of AnalysisMay 25, 2023 E413550
F23161271Certificate of AnalysisMay 25, 2023 E413550
F23161272Certificate of AnalysisMay 25, 2023 E413550
F23161274Certificate of AnalysisMay 25, 2023 E413550
F23161275Certificate of AnalysisMay 25, 2023 E413550
F23161276Certificate of AnalysisMay 25, 2023 E413550
F23161280Certificate of AnalysisMay 25, 2023 E413550
F2317272Certificate of AnalysisMay 25, 2023 E413550
F2317274Certificate of AnalysisMay 25, 2023 E413550

more

Chemical and Physical Properties

SolubilitySolubility (25°C) In vitro DMSO: 78 mg/mL (199.29 mM); Water: Insoluble; Ethanol: Insoluble;
DMSO(mg / mL) Max Solubility78
DMSO(mM) Max Solubility199.294803004752
Water(mg / mL) Max Solubility<1

Related Documents

References

1. Ho SY, Keller TH.  (2015)  The use of porcupine inhibitors to target Wnt-driven cancers..  Bioorg Med Chem Lett,  25  (23): (5472-6).  [PMID:26522946]
2. Madan B, Ke Z, Harmston N, Ho SY, Frois AO, Alam J, Jeyaraj DA, Pendharkar V, Ghosh K, Virshup IH et al..  (2016)  Wnt addiction of genetically defined cancers reversed by PORCN inhibition..  Oncogene,  35  (17): (2197-207).  [PMID:26257057]
3. Ho SY, Alam J, Jeyaraj DA, Wang W, Lin GR, Ang SH, Tan ESW, Lee MA, Ke Z, Madan B et al..  (2017)  Scaffold Hopping and Optimization of Maleimide Based Porcupine Inhibitors..  J Med Chem,  60  (15): (6678-6692).  [PMID:28671458]

Solution Calculators